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Twenty consecutive cases of endograft repair
of traumatic aortic disruption: Lessons learned
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Objectives: Endograft repair holds considerable promise in the treatment of traumatic disruption of the thoracic aorta
because patients often have multiple coexisting injuries further complicating traditional open repair. In addition, patients
are often young, with an aortic anatomy dissimilar to those with atherosclerotic aneurysms. As a result, techniques for
endograft repair have to be refined accordingly.
Methods: The records of 20 consecutive cases of traumatic aortic disruption treated by endograft repair at a single
institution were reviewed.
Results: Mean patient age was 40 years (range, 17 to 88 years), and 17 (85%) of 20 patients were men. All cases were
completed. There were no procedure related deaths, but four (20%) patients died of their co-injuries. Only two (10%) of
20 required a graft >28 mm in diameter, and nine (45%) aortas were small enough to require use of 23-mm abdominal
cuffs. Six (30%) of 20 cases required complete or partial coverage of the left subclavian artery. Placement of a proximal
extension was required in one patient for a type I endoleak. A graft collapse occurred in one patient that required surgical
removal and aortic repair.
Conclusions: Endovascular repair of traumatic aortic disruption can be accomplished in most cases. Compared with
atherosclerotic aneurysms, the proximal thoracic aorta tends to be smaller and the arch angle tighter in an aorta 19mm
in diameter. This frequently necessitates the use of smaller devices and less stiff wires. Surgeons should be prepared to
cover the left subclavian artery if needed, have a wide range of device sizes in stock to avoid over-sizing, and show restraint
if the anatomy appears unsuitable. ( J Vasc Surg 2007;45:487-92.)The development of endovascular techniques in the
treatment of aortic pathology has clearly revolutionized the
practice of vascular surgery. Since its first description by
Parodi et al1 and others in 1991,2 technologic advances
have allowed expansion of indications to beyond simple
aneurysms of the infrarenal aorta. Few conditions lend
themselves so ideally to endograft repair as traumatic dis-
ruption of the aorta. The anatomy is usually favorable, and
patients who present with traumatic aortic disruption have
usually sustained multiple injuries, including injuries of the
chest wall, lungs, abdomen, and brain.3
The current status of traumatic aortic disruption and
traditional repair is not ideal. Approximately 80% to 90% of
patients die in the field.4-6 Of those who make it to the
hospital, the overall mortality is about 32%, with an opera-
tive mortality of 0% to 54% and paraplegia rates of 0% to
36.4%.7
Numerous reports of successful endograft repair have
been published.8-38 The number of cases in each study is
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Fabian et al3 estimate that approximately 7500 to 8000
traumatic aortic disruptions occur in the United States
annually and that about 1000 to 1500 patients arrive at the
hospitals alive. It took 50 centers 2.5 years to generate 274
patients for this prospective report. This averages to just
over two patients per year per center.3
The collective results of these preliminary studies are
encouraging. Our review of the literature identified 23
reports that included five or more patients with acute
traumatic dissection,8-16,23-33,35,37,38 for a total of 220
cases with 15 deaths (6.8%). However, most of these
reports were likely limited by their selective nature and
relatively small patient number. The largest series in this
review was a multicenter retrospective study of 28 cases
with 14% mortality, but it was limited by an unclear
selection process and unknown denominator of total
patients with traumatic aortic injury seen during the
study period. Other studies with a relatively large total
patient number were limited by inclusion of patients
with chronic injury or other emergency patholo-
gy.13,27,33,37 However, regardless of report size or de-
sign, to our knowledge, no reports have been made of
endograft repair of blunt traumatic aortic injury compli-
cated by postoperative paraplegia.
The current report describes our experience with 20
consecutive endograft procedures for repair of traumatic
aortic injury. We believe it represents the largest single-
center experience of endograft repair of acute traumatic
aortic disruption published to date.
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All patients were initially admitted to the R. Adams
Cowley Shock Trauma Hospital trauma resuscitation unit
where initial treatment and diagnostic imaging were per-
formed. With the exception of the first patient, treated in
December 2004, all patients were treated consecutively
between July 2005 and September 2006, and almost all
patients who underwent intervention for blunt traumatic
aortic injury during that time were included. Two patients
underwent open repair primarily: one patient was unstable
and the other had near complete lateral separation of the
thoracic aorta. Both were discharged from the hospital
alive.
All procedures were performed at the University of
Maryland Medical Center, usually in our angiographic op-
erating room suite with fixed imaging equipment (Toshiba
Medical Systems, Tustin, Calif). One exception required
treatment on a standard operating room table with a por-
table C-arm (OEC 9800, GE OEC Medical Systems, Salt
Lake City, Utah). After the first case (D. G. N.), all proce-
dures were performed by the same team, which consisted of a
vascular surgeon (D. G. N.) and cardiac surgeon (B. P. G).
Preoperative computed tomography (CT) was available
in all cases and used for device selection. Devices used
included proximal and distal extension cuffs of the Zenith
TX2 thoracic endograft device (Cook Inc, Bloomington,
Ind) in one case and Gore abdominal aortic extension cuffs
or TAG thoracic endograft devices (W.L. Gore and Asso-
ciates, Flagstaff, Ariz) in the remaining cases, depending on
the size of the native aorta proximal to the injury.
All cases were performed under general endotracheal
anesthesia after life-threatening injuries were treated. The
patients’ abdomen and groins were prepared in the supine
position. A perfusion team was on standby, and the nursing
staff was capable of assisting in both the endovascular
procedure, or should the need arise, open aortic repair with
mechanical perfusion.
The standard operative approach involved open cut-
down of one common femoral artery, chosen on the basis of
preoperative imaging and the extent and location of con-
comitant injuries. Percutaneous access was usually obtained
through the contralateral common femoral artery for place-
ment of a pigtail catheter for intraoperative imaging.
In one case involving a disruption at the level of the
transverse aortic arch, the left common carotid artery was
bypassed by using a graft off the ascending aorta performed
through a median sternotomy. No other adjuvant access
procedures, bypasses, or conduits were required in this
series. No patient had a vascular injury that required exten-
sive repair.
Before device insertion, all patients were systemically
heparinized, usually with 5000 IU of heparin. If not avail-
able preoperatively, initial angiography was performed of
the target and access vessels. On the planned access side, the
initial access wire was exchanged to a stiff wire—either an
Amplatz (Boston Scientific, Miami, Fla) or Lunderquist
(Cook Inc)—for guidance of the selected device. The goalin planning device placement was to preserve the left sub-
clavian artery origin whenever possible.
At the time of device deployment, the patient’s blood
pressure was maintained at a mean of 70 mm Hg. Adeno-
sine was used to produce temporary cardiac arrest during
device deployment in eight patients in the later portion of
our experience. The average dose was 18 mg, although
doses as high as 30 mg were occasionally needed. The
rational for the use of adenosine was somewhat arbitrary
and included reasons such as hyperdynamic state and need
for extra precision in device deployment. We have no
standard protocol for adenosine use at this time.
After device deployment, balloon expansion was used
on all 10 TAG cases, but not the other cases. Completion
arteriograms were performed in all cases to confirm satis-
factory device positioning and resolution of the pseudoan-
eurysm. In procedures in which abdominal cuffs were used,
multiple cuffs were used in all cases. Introducer systems and
sheaths were removed upon completion of device deploy-
ment, and access sites were repaired in standard fashion.
Postoperative CT with intravenous contrast and plain
chest radiographs were obtained 5 days postoperatively.
Routine follow-up surveillance includes a CT scan and
chest radiography 6 months postoperatively and yearly
thereafter.
Injury Severity Scores (ISS) and Revised Trauma Scores
on Admission (RTS-A) were obtained on all patients. A
normal ISS score is 0, with 75 the highest possible score. A
normal RTS score is 7.84. Comparisons of trauma scores
between groups were performed with a two-tailed t test.
RESULTS
The mean age was 40 years (range, 17 to 88 years), and
17 (85%) of the 20 patients were men. All cases were
completed without intraoperative death or complication.
All devices were successfully delivered through a groin
cutdown with no intraoperative conversions to an open
procedure. Four patients died in the postoperative period
for a 30-day mortality of 20%. There were no instances of
paraplegia.
The mechanism of injury was motor vehicle crash in 15
patients, motorcycle crash in three, and fall in two. Twelve
patients underwent endovascular repair 24 hours after
injury. The average delay from injury to repair in the
remaining eight patients was 4 days (range, 2 to 6 days).
The average intraoperative estimated blood loss was
174 mL (range, 50 to 400 mL). The left subclavian artery
was spared in 14 patients, partially covered in four, and
completely covered in two. There were no short-term or
mid-term sequelae of subclavian artery coverage.
From an anatomic standpoint, the average proximal
aortic diameter at the planned landing zone was 22.9 mm
(range, 19 to 30mm). The injury in one patient was located
at the mid arch and required branch exclusion and place-
ment of the graft proximal to the left common carotid
artery. In the remaining 19 cases, the average distance from
the left subclavian artery to the site of injury was 19.9 mm
(range, 0 to 50 mm), and in 14 was 2 cm.
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Zenith TX2 thoracic endograft extension pieces were used
in our first patient. Gore abdominal aortic extension cuffs
were used for the repair in nine of the remaining patients,
and Gore TAG thoracic endografts were used in 10. The
mean graft diameter was 24.7 mm (range, 23 to 34 mm).
For cases in which abdominal cuffs were used, two cuffs
were required in three patients, three cuffs in five patients,
and four cuffs in one patient. For cases in which TAG
thoracic endografts were used, one device was required in
six patients and two devices in four patients. The additional
TAG device in these four patients was required to treat
insufficient proximal landing zone or proximal endoleak.
Average coverage length was 9 cm (range, 4.5 to 15 cm).
Postoperative imaging was available in 19 of 20 pa-
tients, and no endoleak was detected in 16. Of the remain-
ing three, a small proximal endoleak was detected in one
patient on postoperative day 3. This was expected to
thrombose spontaneously, but care was withdrawn before
follow-up studies. One patient had a proximal endoleak
that was successfully treated with a device placed more
proximally, with successful resolution on follow-up imag-
ing. A type I endoleak developed with graft collapse in one
patient that was successfully treated by open explantation
and repair. The early endoleak rate, therefore, was 15.8%
(3/19). No further leaks or device related complications
occurred during an average follow-up of 5.4 months
(range, 1 to 15 months). This includes eight patients with
CT follow-up of 4 months. No patients had endoleak
after discharge. Of the 16 survivors, 14 were discharged in
good condition to acute or subacute rehabilitation facili-
ties, and two were discharged to home. The average length
of stay was 16.5 days. The average length of stay for the
survivors was 19.1 days (range, 8 to 33 days).
The mean ISS was 41.1 and the mean RTS-A was 7.21.
Mean ISS (P  .64) and RTS-A (P  .96) scores were 44
and 7.19 for nonsurvivors and 40.38 and 7.22 for survivors.
In a comparison of patients delayed 24 hour vs those
treated 24 hours, the mean ISS (P  .50) and RTS-A
(P .053) scores were 43.4 and 6.5 in the delay group and
39.6 and 7.7 in the nondelay group.
DISCUSSION
Although endografting may provide a promising alter-
native to a far-from-ideal traditional approach, many ques-
tions still remain unanswered. These cases are not always
straightforward. Currently available devices were not de-
signed for use in young, otherwise healthy, small aortas.
Blunt traumatic lesions are often near the extreme angula-
tion of the aorta. Patients have often sustained multiple
injuries, including head trauma, which create issues related
to the use of systemic anticoagulation. Perhaps of most
importance, the unknown long-term behavior of these
devices will have the greatest impact on patients expected to
live 60 more years.
Clearly, the aortas of young patients are significantly
different compared with the population typically treated for
aneurysmal disease. The young aorta tends to be morenarrow and the turn radius of the aortic arch much tighter.
In our experience, arterial size has not been a problem from
an access standpoint. Although the access vessels may ap-
pear smaller on preoperative imaging or even on the initial
cutdown, a component of reactive vasospasm is often
present. In addition, the access vessels are generally other-
wise healthy and free of calcification and stretch easily to
admit the passage of relatively large sheaths. Fortunately,
the largest available devices and corresponding sheaths are
rarely required in treating transections.
We have found the turn radius in the arch of young
patients to be too tight for the stiffer wires such as the
Lunderquist. It simply cannot be bent to that degree with-
out permanently kinking. In this setting, the Amplatz wire
is sufficiently stiff for easy access, yet is pliable enough to
not kink in a tight aortic arch. There is essentially no iliac or
distal aortic tortuosity in these patients, making delivery of
the device to the proximal aorta quite simple and extra-stiff
wires unnecessary.
The small size of the aorta in young patients does create
new dilemmas that are rarely an issue in patients with
aneurysms. The aortic diameter in transection patients is
often 20 mm in diameter (Fig 1). The smallest thoracic
endograft currently available commercially in the United
States is the 26-mm-diameter Gore TAG device. Attempts
to place this device in aorta 23 mm in diameter can create a
situation of significant oversizing and have been associated
with numerous instances of device collapse.21
We have avoided the issue of oversizing with TAG
devices by using Gore abdominal aortic cuffs in smaller
aortas. These devices are fairly well suited for this purpose
because they are on the longest delivery systems of the
commercially available abdominal devices and have the
shortest tip distal to the device, which is desirable when
working at the aortic arch. All our cases in which the
abdominal cuffs were used were successful and without
endoleak or other complication.
One shortcoming of the abdominal cuffs is obviously
their short length, requiring the use of multiple devices and
creating the potential for device separation. This could be a
particular problem in situations involving a large defect.
Another issue with respect to the abdominal cuffs is the
relatively short delivery system. To this point, we have been
able to deliver the cuffs to the desired location through
femoral access in all cases. However, access through the
iliac arteries should allow delivery of an abdominal cuff to
the distal aortic arch of most tall patients. We have found
Gore abdominal cuffs to be an excellent tool in treating
blunt aortic transection.
Oversizing is only part of the issue of thoracic endograft
device collapse, however. Collapse without excessive over-
sizing has been reported,22 and our case of collapse also
occurred without oversizing. Probably the more important
factor related to device collapse is lack of device opposition
to the aortic wall as it enters the horizontal portion of the
aortic arch (Fig 2). Such malpositioning subjects the device
to extreme tangential forces and causes collapse with a fair
degree of predictability. Options for treatment of device
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patient, or insertion of a second stent graft device or
balloon-expandable stent within the collapsed device.21,22
We would recommend particular attention in planning a
treatment strategy in cases involving a transection at or very
close to the left subclavian artery in a tightly curved aortic
Fig 1. A, The predeployment angiogram of a 17-year-old boy
with a 19-mm aorta demonstrates a traumatic aortic pseudoaneu-
rysm. Use of a 26-mm TAG device would have caused significant
oversizing. B, The completion angiogram after placement of three
23-mmGore abdominal aortic cuffs demonstrates exclusion of the
pseudoaneurysm and preserved patency of the left subclavian ar-
tery.arch.Fig 2. A,This preoperative computed tomography (CT) scan dem-
onstrates aortic transection with pseudoaneurysm in a 23-year-old
man with a 24-mm aorta. B,Completion angiogram after placement
of a 26-mmTAGdevice.Note extension of device into lumenof aorta
(arrow) with presence of endoleak (arrowhead). C, A CT scan on
postoperative day 6 demonstrates collapse of the TAG device.
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ment of aortic transection is whether to cover the left
subclavian artery. It has become fairly well accepted that
coverage of this vessel is usually safe, but is not without
complication. Perhaps of more importance, however, is
that coverage of the left subclavian artery brings the device
into the transverse portion of the aortic arch. This subjects
the devices to collapse, as just discussed, or it may provide a
lip for blood to track under and create a proximal endoleak.
It is our opinion and experience that the left subclavian
artery does not need to be covered in most cases.
It is well documented that most aortic tears occur at the
isthmus.6,39 The tear in our series occurred an average of
19.9 mm from the origin of the left subclavian artery, with
14 of 20 tears being of 2 cm distance. In addition, it is
likely that the previously normal aorta at the site of injury
will heal over time. In short, the total length of fixationmay
not need to be as long as required for long-term satisfactory
outcomes in the endograft repair of atherosclerotic aneu-
rysms.
Obviously, answers to questions about the long-term
behavior of these devices and the involved aorta will only be
answered by careful long-term follow-up. A widely preva-
lent observation is that it is notoriously difficult to maintain
close follow-up of trauma patients over time. A victim of
penetrating trauma may have a number of reasons for not
wanting to be easily found; however, this is not generally
the case in patients with blunt aortic injury. In addition,
vascular surgeons have well-established mechanisms for the
long-term follow-up of their patients. We have not have
had any difficulty maintaining contact will all of our surviv-
ing patients, although one patient did move to a distant
state and arrangements were made for follow-up by a
different vascular group.
Other unanswered questions involve timing of repair
and anticoagulation with respect to the patient’s other
injuries, particularly head trauma. Up to this point, we have
been reluctant to avoid systemic anticoagulation during
endografting procedures because of concerns of potential
thromboembolic complications. In cases of head trauma,
we have delayed treatment until anticoagulation was no
longer contraindicated; this delay averaged about 4 days.
Although trauma scores trended toward more severe injury
in the group in whom repair was delayed 24 hours, the
main reason for delay in this series was head injury and
anticoagulation concerns. Our comfort with a selective
delayed approach in stable patients who can tolerate judi-
cious blood pressure control is based on reports of the
safety of a delayed approach.40 With this protocol, six of the
eight patients in our series with head injuries underwent a
successful repair and were discharged from the hospital
neurologically intact. One patient with massive head injury
and a tear in the transverse aortic arch and one elderly
patient with multiple other injuries and abdominal sepsis
did not survive, however.
The reasons to consider an alternative approach are
compelling. Although most authors of published reports
used heparin routinely, excellent outcomes have been re-ported with selective use or even complete avoidance of
anticoagulation.8,29 Clearly, by not requiring systemic an-
ticoagulation, patients with head injuries could be treated
earlier, thereby simplifying blood pressure management
issues.
Despite what appears to be a less invasive approach, the
mortality in our series was a disappointing 20%. The four
deaths were due to dysrhythmia in the setting of cardiac
contusion, brain injury, intra-abdominal sepsis, and pulmo-
nary embolism. Of interest was that trauma scores between
survivors and nonsurvivors were similar, suggesting it
would be difficult to predict outcome before aortic repair.
As with all other series we are aware of, the paraplegia
rate in our experience was zero. This is likely due to the
absence of aortic clamping and intraoperative hypotension
and also to the location and relative short length of aorta
covered.
As for the future, technologic advances will create
endograft designs even more suitable for the treatment of
traumatic aortic injury. Devices designed for this purpose
will likely have a covered proximal aspect without flares.
The proximal end will require more frequent, smaller artic-
ulations to better appose to the inner wall in the turn of the
aortic arch. A broader range of diameters and lengths will
be available. The ideal device would also allow for more
precise placement and not be subject to the blood forces in
the proximal aorta. Even more sophisticated devices may
have a scallop at the outer curve and a covered flap designed
to fully appose to the inner curve of the aorta.
CONCLUSION
We believe this report provides a relatively large expe-
rience to the growing body of literature about endograft
repair of traumatic aortic transection. Although retrospec-
tive in design, the involvement of a single surgical team over
a short period of time helps reduce confounding variables.
With two exceptions, this series includes all transections
treated at our institution during the stated time period and,
therefore, essentially eliminates selection bias. Endovascu-
lar approaches to traumatic aortic injury hold great prom-
ise, particularly as improved devices become available and if
long-term results remain excellent.
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